Prelude Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Prelude Capital Management, LLC
- $1.85 Billion
- Q1 2024
A detailed history of Prelude Capital Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 15,200 shares of TARS stock, worth $418,760. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,200
Previous 20,000
24.0%
Holding current value
$418,760
Previous $405,000
36.3%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
166Shares Held
39.5MCall Options Held
190KPut Options Held
92.9K-
Rtw Investments, LP New York, NY3.27MShares$90.2 Million1.91% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.86MShares$78.9 Million3.9% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$73.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$66.1 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$62.1 Million9.98% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $734M
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...